Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Berberine, a well-known alkaloid, has been proved to possess various pharmacological activities. Previous studies demonstrated that berberine could be extensively metabolized and the metabolites also contributed to its therapeutic effects. However, as for berberine’s metabolites, especially phase II metabolites, pharmacokinetics and excretion studies were rarely reported. The objective of this study was to thoroughly investigate the pharmacokinetic and excretion profiles of berberine and its nine metabolites, namely, berberrubine (M1), demethyleneberberine (M2), jatrorrhizine (M3), jatrorrhizine-3-O-β-D-glucuronide (M4), jatrorrhizine-3-O-sulfate (M5), thalfendine-10-O-β-D-glucuronide (M6), berberrubine-9-O-β-D-glucuronide (M7), demethyleneberberine-2-O-sulfate (M8) and demethyleneberberine-2-O-β-D-glucuronide (M9) in rats. An accurate and reliable LC-MS/MS method was developed and validated for the determination of berberine and its nine metabolites in rat biosamples. Pharmacokinetic profiles of berberine and its nine metabolites were obtained after a single intravenous administration (4.0 mg/kg) and oral administration (48.2, 120 or 240 mg/kg) of berberine in rats. For excretion study, rats were intragastrically administered a single dose of 48.2 mg/kg berberine. Our results showed that berberine could be metabolized rapidly and all the nine metabolites could be detected in vivo. The absolute bioavailability of berberine was 0.37 ± 0.11%. As for the AUC 0–48 h values, phase II metabolites were much higher than those of phase I metabolites, suggesting that phase II metabolites were the major metabolites exist in blood circulation. 18.6% of the berberine was excreted in feces as berberrubine (M1). The total recovery of berberine and its nine metabolites from urine, bile and feces was 41.2%. This is the first systematic study about the pharmacokinetics and excretion of berberine and its nine metabolites, which will be beneficial for both better understanding the clinical effects and further development of berberine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363 · cited 2×
“Secondly, it had been reported that berberine was a substrate of P-gp and the bioavailability of berberine was greatly limited by this ATP-dependent multidrug transporter (Chen et al., 2011).”
BackgroundResultLiu, Y.-T., Hao, H.-P., Xie, H.-G., Lai, L., Wang, Q., Liu, C.-X., & Wang, G.-J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033936 · Cited by 356
Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
Tan, X.-S., Ma, J.-Y., Feng, R., Ma, C., Chen, W.-J., Sun, Y.-P., Fu, J., Huang, M., He, C.-Y., Shou, J.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077969 · Cited by 266 · cited 1×
“Pharmacokinetic studies of berberine have been conducted by several investigators, and it has been revealed that berberine undergoes extensive metabolism and the oral bioavailability of berberine is really low (Zuo et al., 2006; Hua et al., 2007; Liu et al., 2010; Ma et al., 2013; Tan et al., 2013; Feng et al., 2018).”
BackgroundSpinozzi, S., Colliva, C., Camborata, C., Roberti, M., Ianni, C., Neri, F., Calvarese, C., Lisotti, A., Mazzella, G., & Roda, A. (2014) · Journal of Natural Products · doi:10.1021/np400607k · Cited by 161 · cited 1×
“Firstly, berberine (pKa ∼15) (Spinozzi et al., 2014) was mostly in the ionized form at physiological condition, thus, only a few could be absorbed after oral administration.”
BackgroundZhou, Y., Cao, S., Wang, Y., Xu, P., Yan, J., Bin, W., Qiu, F., & Kang, N. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.11.010 · Cited by 81
Self-citationZhang, P., Qiang, X., Zhang, M., Ma, D., Zhao, Z., Zhou, C., Liu, X., Li, R., Chen, H., & Zhang, Y. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219832 · Cited by 78 · cited 1×
“As for the phase I metabolites of berberine, demethyleneberine was proved to show anti-inflammatory and hepatoprotective effects and could be serve as a potential therapy for liver disease, hepatic fibrosis and autoimmune hepatitis (Zhang et al., 2015; Qiang et al., 2016; Wang et al., 2016; Chen et al., 2017; Zhang et…”
BackgroundMin, Y. D., Yang, M. C., Lee, K. H., Kim, K. R., Choi, S. U., & Lee, K. R. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02974076 · Cited by 65
Cited by
Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
Han, Y., Xiang, Y., Shi, Y., Tang, X., Pan, L., Gao, J., Bi, R., & Lai, X. (2021) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2021/9987097 · Cited by 51
“According to relevant experimental studies [36, 37], it is not difficult to find that, for rats, feces are the main excretion method during gavage or oral administration, and BBR in feces is mainly excreted in its original form.”
BackgroundMurakami, T., Bodor, E., & Bodor, N. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2203857 · Cited by 41
Dehau, T., Cherlet, M., Croubels, S., Van De Vliet, M., Goossens, E., & Van Immerseel, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1281090 · Cited by 33
Biodistribution and pharmacokinetic profile of berberine and its metabolites in hepatocytes
Liu, X., Li, W., Zhang, H., Wang, X., Huang, Y., Li, Y., & Pan, G. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154288 · Cited by 27
Sex‐Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans
Blöcher, J. A., Meyer‐Tönnies, M. J., Morof, F., Rönnpagel, V., Bethmann, J., Vollmer, M., Engeli, S., & Tzvetkov, M. V. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3454 · Cited by 16
“22 Using human liver microsomes, CYP2D6, and to a lesser extent, CYP1A2 have been confirmed as potential metabolizing enzymes of berberine in humans.”
Metadata
- Authors
- Feng, X., Wang, K., Cao, S., Ding, L., & Qiu, F.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-15
- Volume
- 11
- Pages
- 594852-594852
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3121845936
- Cited by
- 126
- References
- 8
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats. https://app.cochat.ai/papers/10.3389/fphar.2020.594852
- The paper
- Feng, X., Wang, K., Cao, S., Ding, L., & Qiu, F. (2021). Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2020.594852
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.